KORU Medical Systems, Inc.

NASDAQ:KRMD

Medical - Instruments & Supplies

Healthcare
$3.45 +1.55%

+$0.06 today

Market cap
$149.64M
Beta
0.42
P/E (TTM)
-80.2
EPS (TTM)
-$0.05
52W Low $2.91High $6.61

Volume 0.19M

Average 0.13M

KRMD Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

KORU Medical Systems, Inc.NASDAQ: KRMD

Operating Expenses · Q1 FY2026 · quarter ended Mar 2026

Operating expenses growth accelerates

Q1 FY2026 operating expenses of $7.9M rose 8.3% year over year, ahead of the +4.2% change in trailing-twelve-month operating expenses. Sequentially, it rose 7.3% from the prior quarter. Over 3 fiscal years it compounded at +3.0% a year.

Context

  • Operating expenses amounted to 69.5% of revenue in FY2025, down 13.1 pp from a year earlier.
  • Operating expenses increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +8.3% holds above the trailing-twelve-month pace of +4.2%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$7.9M+7.3% QoQ
Last fiscal yearDec 2025
$28.58M+2.9% YoY
LTMMar 2026
$29.18M+4.2% YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+8.3%——
1 year+2.9%——
3-year CAGR+3.0%——
5-year CAGR——
10-year CAGR——

Operating Expenses history

USD · from the income statement

Latest · FY2025
28.58M USD
Year-over-year change
+2.9%
4-year CAGR
+8.3%

Operating Expenses vs competitors

How KRMD compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +4.2% is the 7th highest of 10, against a peer median of +6.9%.
  • Operating expenses amounts to 67.5% of revenue for KRMD, versus a peer median of 105.6%.
KRMD Competitors
Operating Expenses for KRMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
OSUROraSure Technologies, Inc.LTM Mar 2026$119.39M USD+14.5%-8.9%105.6%
PREPrenetics Global LimitedLTM Mar 2026$104.66M USD+52.6%+7.7%92.0%
STIMNeuronetics, Inc.LTM Mar 2026$102.14M USD+6.9%+6.9%67.4%
NYXHNyxoah S.A.LTM Mar 2026€93.92M EUR+34.0%+37.4%575.6%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$67.92M USD+4.9%+5.1%47.7%
TLSITriSalus Life Sciences, Inc.LTM Mar 2026$66.21M USD+11.6%+11.8%147.5%
MXCTMaxCyte, Inc.LTM Mar 2026$64.71M USD-20.8%+2.7%200.4%
PROFProfound Medical Corp.LTM Mar 2026$51.76M USD-47.5%+15.1%274.3%
KRMDKORU Medical Systems, Inc.LTM Mar 2026$29.18M USD+4.2%+3.0%67.5%
UTMDUtah Medical Products, Inc.LTM Mar 2026$9.32M USD+3.3%-11.9%24.8%
Peer median (excluding KRMD) —+6.9%+6.9%105.6%

Competitors are the stored peer set for KRMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue23.49M27.9M28.52M33.65M41.13M
Cost of Revenue9.72M12.53M11.81M12.31M15.52M
Gross Profit13.77M15.37M16.71M21.33M25.6M
Gross Margin58.6%55.1%58.6%63.4%62.3%
Research & Development2.47M4.96M5.74M5.26M4.39M
Selling, General & Admin000023.38M
Operating Expenses20.8M26.15M26.98M27.78M28.58M
Depreciation & Amortization463.13K587.14K870.39K772.89K810.5K
EBITDA(5.9M)(10.09M)(8.9M)(5.29M)(1.81M)
EBITDA Margin-25.1%-36.2%-31.2%-15.7%-4.4%
Operating Income(7.03M)(10.78M)(10.27M)(6.45M)(2.97M)
Operating Margin-29.9%-38.6%-36.0%-19.2%-7.2%
Interest Income13.08K145.59K561.33K444.64K293.4K
Interest Expense00000
Other Income / Expenses665.09K105.71K496.4K382.49K356.41K
Income Before Tax(6.36M)(10.68M)(9.77M)(6.06M)(2.62M)
Pre-Tax Margin-27.1%-38.3%-34.3%-18.0%-6.4%
Income Tax Expense(1.8M)(2.01M)3.97M2.89K21.89K
Net Income(4.56M)(8.66M)(13.74M)(6.07M)(2.64M)
Net Margin-19.4%-31.0%-48.2%-18.0%-6.4%
EPS (Basic)(0.10)(0.19)(0.30)(0.13)(0.06)
EPS (Diluted)(0.10)(0.19)(0.30)(0.13)(0.06)
Weighted Avg Shares44.39M45M45.6M45.8M46.19M
Weighted Avg Shares (Diluted)44.39M45M45.6M45.8M46.19M

KORU Medical Systems, Inc.

NASDAQ:KRMD

Intrinsic Alpha fair value

Locked

Current Price

$3.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.